A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02014142
Recruitment Status : Completed
First Posted : December 18, 2013
Last Update Posted : January 18, 2017
Information provided by (Responsible Party):
Mati Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : December 2016
  Certification/Extension First Submitted : January 9, 2017